文献速递其他结缔组织病系统性红斑狼疮自身炎症与 IgG4 相关病

血浆置换联合标准免疫抑制治疗对成人自身免疫炎症性风湿病相关巨噬细胞活化综合征的疗效:单中心真实世界分析

Efficacy of plasma exchange on top of standard immunosuppressive therapy in adult autoimmune inflammatory rheumatic diseases-associated macrophage activation syndrome, a single center real-world analysis.
PubMed 文献 · Semin Arthritis Rheum · 2022-06-07

基于同济医院2014至2020年5775例自身免疫炎症性风湿病患者中收集的62例相关巨噬细胞活化综合征病例,分析不同治疗尤其是血浆置换的疗效。血浆置换后多种炎症细胞因子迅速下降,铁蛋白、乳酸脱氢酶和C反应蛋白等指标改善,LASSO回归显示血浆置换与死亡率显著降低相关(从53.6%降至11.8%),经IPTW校正混杂因素后HR为0.148(p<0.001)。结论认为在糖皮质激素和免疫抑制剂背景治疗下,血浆置换是快速清除炎症细胞因子并降低死亡率的有效方法。

要点

  • 62例患者均接受糖皮质激素,87.1%使用至少一种免疫抑制剂,54.8%接受血浆置换。
  • 血浆置换后炎症细胞因子迅速降低,铁蛋白、乳酸脱氢酶和C反应蛋白改善。
  • LASSO回归显示血浆置换与死亡率从53.6%降至11.8%相关,IPTW校正后HR为0.148(p<0.001)。

核心结论

  • 在糖皮质激素和免疫抑制剂背景治疗下,血浆置换是快速清除炎症细胞因子并降低自身免疫炎症性风湿病相关巨噬细胞活化综合征死亡率的有效方法。

研究设计与样本

  • 单中心真实世界分析,纳入同济医院2014至2020年5775例自身免疫炎症性风湿病患者中的62例相关巨噬细胞活化综合征病例。
  • 采用未校正逻辑回归、LASSO回归和逆概率治疗加权(IPTW)分析临床特征及预后相关因素,配对t检验比较血浆置换前后炎症指标变化。

主要发现

  • 自身免疫炎症性风湿病中巨噬细胞活化综合征患病率为1.1%,最常见类型为系统性红斑狼疮(45.2%)和成人起病Still病(33.9%)。
  • 62例患者均接受糖皮质激素,87.1%使用至少一种免疫抑制剂,54.8%接受血浆置换。
  • 血浆置换后多种炎症细胞因子血清水平迅速降低,伴随临床症状及铁蛋白、乳酸脱氢酶、C反应蛋白等实验室指标改善。
  • LASSO回归显示血浆置换与死亡率从53.6%降至11.8%相关,经IPTW校正混杂因素后HR为0.148(p<0.001)。

关键数值与推荐

  • 巨噬细胞活化综合征在自身免疫炎症性风湿病中的患病率为1.1%。
  • 最常见自身免疫炎症性风湿病类型为系统性红斑狼疮(45.2%)和成人起病Still病(33.9%)。
  • 62例患者中87.1%使用至少一种免疫抑制剂,54.8%接受血浆置换。
  • 血浆置换与死亡率从53.6%降至11.8%相关,IPTW校正后HR为0.148(p<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is a lack of documented real-world evidence about the efficacy of current therapeutics for autoimmune inflammatory rheumatic diseases (AIIRD)-associated adult macrophage activation syndrome (MAS). OBJECTIVE: To analyze the efficacy of different treatments, especially plasma exchange (PE), in AIIRD-associated MAS. METHODS: Among 5775 patients with AIIRD in Tongji Hospital from 2014 to 2020, 62 AIIRD-associated MAS cases were collected. Unadjusted logistic regression, least absolute shrinkage and selection operator (LASSO), and inverse probability of treatment weight (IPTW) analyses were used to characterize the clinical features and potential factors related to the prognosis. Paired t-test was used to compared the changes of inflammatory indicators before and after PE treatment. RESULTS: The baseline data was defined as the data collected at the onset of MAS, and all of the 62 patients were diagnosed as AIIRD before MAS onset. The prevalance rate of MAS in AIIRD was 1.1%, and the most common types of AIIRD were systemic lupus erythematosus (45.2%) and adult-onset Still's disease (33.9%). All 62 MAS patients received glucocorticoids, 87.1% patients used at least one immunosuppressive agent, and 54.8% received PE. LASSO regression indicates a positive effect of PE on the basis of variables. After PE treatment, serum levels of multiple inflammatory cytokines were rapidly reduced, accompanied by improvements in clinical symptoms and laboratory indecies including ferritin, lactate dehydrogenase, and C-reactive protein. LASSO regression indicates that PE treatment was associated with a marked reduction of mortality (from 53.6% to 11.8%), with a hazard ratio (HR) of 0.148 (p < 0.001) after adjustment for confounding factors using IPTW analysis. CONCLUSION: With the background therapy of glucocorticoids and immunosuppressive agents, PE is an effective approach to rapidly clear inflammatory cytokines and reduce mortality of AIIRD-associated MAS. CLINICAL IMPLICATION: This study provided real-world information on the efficacy of PE in AIIRD-associated MAS.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Chen Y, Hu Z, Cai S, et al. Efficacy of plasma exchange on top of standard immunosuppressive therapy in adult autoimmune inflammatory rheumatic diseases-associated macrophage activation syndrome, a single center real-world analysis. Semin Arthritis Rheum. 2022. PMID: 35696776. doi:10.1016/j.semarthrit.2022.152043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。